NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

IVF

INVO Fertility Inc

May 19 • 04:00PM ET

2.17

Dollar change +0.18
Percentage change 9.05	%

Healthcare • Medical Devices • USA • NASD

Peers: LLY MRK ABBV PFE BMY VRTX REGN GILD AMGN BIIB

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-28.11	Insider Own	9.79%	Shs Outstand	1.07M	Perf Week	1.88%
Market Cap	2.31M	Forward P/E	-	EPS next Y	-0.98	Insider Trans	0.00%	Shs Float	0.96M	Perf Month	13.02%
Income	-9.35M	PEG	-	EPS next Q	-	Inst Own	10.70%	Short Float	10.81%	Perf Quarter	-50.43%
Sales	6.53M	P/S	0.35	EPS this Y	96.32%	Inst Trans	373.53%	Short Ratio	0.05	Perf Half Y	-78.58%
Book/sh	-47.26	P/B	-	EPS next Y	11.71%	ROA	-27.02%	Short Interest	0.10M	Perf Year	-83.10%
Cash/sh	0.69	P/C	3.12	EPS next 5Y	60.65%	ROE	-133.37%	52W Range	1.38 - 17.04	Perf YTD	-77.67%
Dividend Est.	-	P/FCF	-	EPS past 5Y	22.38%	ROI	-39.73%	52W High	-87.27%	Beta	2.26
Dividend TTM	-	Quick Ratio	0.06	Sales past 5Y	114.91%	Gross Margin	29.92%	52W Low	57.25%	ATR (14)	0.38
Dividend Ex-Date	-	Current Ratio	0.07	EPS Y/Y TTM	72.96%	Oper. Margin	-116.56%	RSI (14)	51.18	Volatility	10.03% 19.97%
Employees	37	Debt/Eq	1.36	Sales Y/Y TTM	116.25%	Profit Margin	-143.09%	Recom	1.00	Target Price	6.00
Option/Short	No / Yes	LT Debt/Eq	0.85	EPS Q/Q	-10.04%	Payout	-	Rel Volume	0.26	Prev Close	1.99
Sales Surprise	12.40%	EPS Surprise	-158.29%	Sales Q/Q	22.02%	Earnings	Apr 30 BMO	Avg Volume	2.18M	Price	2.17
SMA20	7.93%	SMA50	-2.20%	SMA200	-69.02%	Trades		Volume	575,669	Change	9.05%

Apr-30-25 09:00AM	INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA (GlobeNewswire) +48.45%
Apr-24-25 09:00AM	INVO Fertility Confirms New Nasdaq Trading Symbol of IVF (GlobeNewswire) +5.73%
Apr-14-25 07:30PM	NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations Company Renamed INVO Fertility, Inc. (GlobeNewswire) +8.65% -16.37%
Mar-13-25 04:30PM	NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025 (GlobeNewswire) -33.76%
Feb-25-25 08:00AM	NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment (GlobeNewswire) -6.33%
09:15AM	Loading…
Feb-19-25 09:15AM	NAYA Biosciences Announces Nomination of New Board Members (GlobeNewswire)
Jan-13-25 09:15AM	NAYA Biosciences Announces Pricing of $9.5 Million Public Offering (GlobeNewswire) -38.53%
Jan-06-25 08:30AM	NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody (GlobeNewswire) +9.74%
Oct-31-24 09:00AM	NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC) (GlobeNewswire)
Oct-24-24 09:00AM	NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma (GlobeNewswire)
Oct-21-24 09:00AM	INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences (GlobeNewswire)
Oct-14-24 09:18AM	INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA) (GlobeNewswire) +89.31%
Aug-14-24 09:00AM	INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA (GlobeNewswire)
May-15-24 09:53PM	INVO Stock Earnings: INVO Bioscience Reported Results for Q1 2024 (InvestorPlace) -6.54%
04:15PM	INVO Reports Record First Quarter 2024 Financial Results (GlobeNewswire)
07:34AM	Loading…
May-14-24 07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) -8.20%
Apr-17-24 08:16AM	Why Is Invo Bioscience (INVO) Stock Up 85% Today? (InvestorPlace) +139.47%
Apr-16-24 09:53PM	INVO Stock Earnings: INVO Bioscience Reported Results for Q4 2023 (InvestorPlace)
04:59PM	INVO Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-23-24 08:00AM	NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON) (GlobeNewswire) +6.80%
Jan-17-24 08:00AM	INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors (GlobeNewswire) +12.38%
Dec-11-23 08:00AM	NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal (PR Newswire)
Dec-06-23 09:00AM	NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies (PR Newswire)
Nov-28-23 09:00AM	INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement (PR Newswire) -12.02%
Nov-13-23 04:01PM	INVO Reports Record Third Quarter 2023 Financial Results (PR Newswire) +22.90% +34.16%
08:15AM	BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger (News Direct)
Nov-10-23 09:00AM	NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger (PR Newswire) +90.68%
Nov-09-23 04:40PM	INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants (PR Newswire) -12.13%
Oct-27-23 09:00AM	Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023 (PR Newswire) -5.80%
Oct-24-23 10:08AM	Moore Kuehn Encourages INVO, ESMT, HES, and TGH Investors to Contact Law Firm (GlobeNewswire) -30.19%
08:45AM	Loading…
08:45AM	Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments (PR Newswire)
Oct-23-23 01:40PM	Why Is INVO Bioscience (INVO) Stock Up 325% Today? (InvestorPlace) +292.59%
07:30AM	INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company (PR Newswire)
Oct-11-23 09:00AM	INVO to Participate in the Lytham Partners Fall 2023 Investor Conference (PR Newswire) -10.16%
Sep-29-23 04:05PM	INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS (PR Newswire) -7.59%
Sep-28-23 12:30PM	INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET (PR Newswire)
Aug-14-23 04:05PM	INVO Reports Second Quarter 2023 Financial Results (PR Newswire) -15.68%
Aug-11-23 08:00AM	INVO Closes Acquisition of Wisconsin Fertility Institute (PR Newswire) -6.82%
Aug-09-23 04:15PM	INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 (PR Newswire) -5.38%
Aug-08-23 01:55PM	INVO Bioscience Announces Closing of $4.5 Million Public Offering (PR Newswire)
Aug-04-23 09:00AM	INVO Bioscience Announces Pricing of $4.5 Million Public Offering (PR Newswire) -36.71%
Aug-03-23 08:00AM	INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value (PR Newswire) -20.20%
Jul-27-23 09:26AM	INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023 (PR Newswire) +22.53%
Jun-27-23 09:00AM	INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device (PR Newswire) -8.75%
May-15-23 04:05PM	INVO Reports First Quarter 2023 Financial Results (PR Newswire)
May-08-23 04:15PM	INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 (PR Newswire) -8.25%
Apr-17-23 04:05PM	INVO Reports Fourth Quarter and Full Year 2022 Financial Results (PR Newswire) +8.30% -11.53%
Apr-11-23 05:30PM	INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023 (PR Newswire) -6.49%
Apr-05-23 09:00AM	INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek (PR Newswire)
Mar-30-23 05:25PM	INVO Provides Preliminary Update on FY2022 Financial Results (PR Newswire) +6.45%
Mar-27-23 05:06PM	INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering (PR Newswire)
Mar-24-23 08:00AM	INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market (PR Newswire) -8.70%
Mar-20-23 09:00AM	INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute (PR Newswire) +14.42%
Jan-05-23 09:00AM	INVO Bioscience Enters Distribution Agreement for Taiwan (PR Newswire) +6.96%
Jan-03-23 09:00AM	INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center (PR Newswire)
Nov-30-22 09:30AM	First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology (PR Newswire)
Nov-14-22 04:05PM	INVO Bioscience Reports Third Quarter 2022 Financial Results (PR Newswire) +5.08%
Nov-10-22 04:15PM	INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 (PR Newswire) +11.00%
Nov-01-22 09:00AM	INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo (PR Newswire)
Oct-21-22 09:00AM	INVOcell Review Published in Current Opinion in Obstetrics and Gynecology (PR Newswire)
Oct-17-22 09:00AM	INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo (PR Newswire)
Sep-22-22 09:00AM	Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly (PR Newswire) -11.57%
Aug-25-22 09:00AM	INVOcell Launched in Malaysia by Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz (PR Newswire)
Aug-15-22 04:05PM	INVO Bioscience Reports Second Quarter 2022 Financial Results (PR Newswire) +5.61% -7.96%
Aug-04-22 04:15PM	INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022 (PR Newswire)
Jul-07-22 08:00AM	INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment (PR Newswire) +7.31%
May-16-22 04:15PM	INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China (PR Newswire) +10.25%
04:05PM	INVO Bioscience Reports First Quarter 2022 Financial Results (PR Newswire)
May-09-22 04:30PM	INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022 (PR Newswire) -18.50%
Apr-28-22 09:00AM	INVO Celebrates National Infertility Awareness Week at the INVO Center in Atlanta, Georgia (PR Newswire)
Apr-14-22 09:00AM	INVO Selects Kansas City as additional INVO Center Location (PR Newswire) -8.74%
Apr-04-22 09:00AM	INVO Bioscience to Participate in the Lytham Partners Spring 2022 Investor Conference (PR Newswire) +7.38%
Mar-31-22 04:05PM	INVO Bioscience Reports 2021 Financial Results (PR Newswire) -6.06%
Mar-24-22 04:15PM	INVO Bioscience to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Thursday, March 31, 2022 (PR Newswire)
09:00AM	INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting (PR Newswire)
Mar-22-22 09:00AM	INVO Bioscience to Participate in Roundtable Discussion at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest (PR Newswire)
Mar-10-22 09:00AM	New Birmingham INVO Center Offers Families an Affordable Advanced Fertility Treatment Solution to Help Combat Rising Costs (PR Newswire)
Feb-16-22 09:00AM	INVO to Launch Additional INVO Center in Tampa, Florida (PR Newswire)
Feb-09-22 08:00AM	INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment 'INVO Centers' (ACCESSWIRE Test RSS)
Feb-03-22 09:00AM	INVO Bioscience Expands U.S. Commercialization Efforts (PR Newswire) +5.01%
Dec-16-21 09:00AM	INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialization (PR Newswire)
Dec-10-21 02:05PM	INVO Bioscience to Participate in the Lytham Partners Winter 2021 Investor Conference (PR Newswire)
Dec-01-21 09:00AM	INVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In Thailand (PR Newswire)
Nov-15-21 04:05PM	INVO Bioscience Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update (PR Newswire)
Nov-09-21 04:15PM	INVO Bioscience to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021 (PR Newswire)
Nov-08-21 04:15PM	INVO Bioscience Regains Full U.S. Commercialization Rights (PR Newswire)
03:00PM	Will Invo BioScience Inc. (INVO) Report Negative Q3 Earnings? What You Should Know (Zacks)
Oct-20-21 09:00AM	INVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo (PR Newswire)
Oct-14-21 09:00AM	INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021 (PR Newswire) +11.33%
Oct-01-21 09:29AM	INVO Bioscience Announces $4.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire)
Sep-09-21 08:00AM	INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada (PR Newswire)
Sep-07-21 09:00AM	INVO Bioscience Announces Official Opening of "Bloom Fertility, an INVO Center" in Atlanta (PR Newswire)
Sep-03-21 09:00AM	Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual AFRH Virtual Conference (PR Newswire)
Aug-16-21 04:05PM	INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update (PR Newswire) -6.59%
Aug-05-21 04:15PM	INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021 (PR Newswire)
03:01PM	Invo BioScience Inc. (INVO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release (Zacks)
Aug-02-21 04:05PM	INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama (PR Newswire)
Jul-14-21 08:30AM	INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration (PR Newswire)
Jun-30-21 09:30AM	INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta (PR Newswire)
Jun-15-21 09:00AM	INVO Bioscience Appoints Andrea Goren as Chief Financial Officer (PR Newswire) -11.50%

INVO Fertility, Inc. operates a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on October 14, 2024 and is headquartered in Sarasota, FL.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IVF

INVO Fertility Inc

Upgrade your FINVIZ experience